| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BNTAS
|
6.18 | 1.5B | 5.89 | 0.88 | 6.56 | 13.8% | 43.7% | 72 | 27 | 11.57 | +62.8% | 96 | 0.03 |
|
MNDTR
|
4.89 | 4.6B | 5.37 | 2.33 | 4.54 | 33.7% | 38.0% | 72 | 38 | 7.87 | +44.0% | 71 | 0.57 |
|
BARMA
|
8.10 | 2.1B | 8.44 | 0.57 | 8.25 | 2.0% | 18.5% | 66 | 52 | 17.08 | +83.1% | 32 | 1.16 |
|
GEDZA
|
28.46 | 1.3B | — | 1.12 | 6.78 | 13.6% | 44.1% | 57 | 32 | 38.11 | +21.7% | 86 | 0.02 |
|
BAKAB
|
38.24 | 2.8B | — | 0.89 | 7.38 | 1.7% | 32.8% | 55 | 24 | 54.59 | +25.2% | 54 | 0.38 |
|
KRPLS
|
10.49 | 1.8B | — | 1.96 | 6.83 | 10.7% | 42.8% | 46 | 27 | 10.02 | -2.7% | 58 | 0.24 |
|
DURDO
|
5.10 | 2.5B | — | 1.63 | 21.00 | -2.7% | 35.1% | 36 | 28 | 4.59 | -5.1% | 34 | 0.58 |
|
EMNIS
|
149.90 | 929.4M | 100.00 | 59.55 | 27.02 | 47.9% | 44.5% | 31 | 24 | 39.72 | -55.1% | 97 | 0.00 |
|
OZRDN
|
30.40 | 2.2B | — | 6.32 | — | -3.1% | 44.5% | 30 | 24 | 11.18 | -30.4% | 81 | 0.01 |
|
SEKUR
|
10.35 | 1.9B | 45.45 | 3.26 | 14.08 | 9.3% | 36.3% | 26 | 25 | 5.98 | -30.4% | 38 | 1.08 |
|
KAPLM
|
389.00 | 7.8B | — | 11.77 | 140.40 | 1.0% | 41.3% | 22 | 16 | 97.25 | -38.2% | 44 | 0.39 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.